Transdermal lidocaine patch for acute postoperative pain in laparoscopic gynecologic operation: A randomized controlled trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

TCTR

Registry ID

TCTR20210707001

Enrollment

110

Registered

2021-07-07

Start date

2020-08-14

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-malignancy gynecologic condition Transdermal lidocaine patch acute postoperative pain laparoscopic gynecologic operation

Interventions

transdermal lidocaine patch Each Lignopad contains lidocaine 50 mg per g adhesive base. Each medicated plaster contains the following excipients: Self-Adhesive Layer: Glycerol, crystallizing liquid so

Experimental Drug,Placebo Comparator No treatment

transdermal lidocaine patch,placebo

Eligibility

Sex/Gender

Female

Age

15 Years to 65 Years

Inclusion criteria

Inclusion criteria: Age 18-65 years old Laparoscopic gynecologic procedure

Exclusion criteria

Exclusion criteria: Opioid allergy

Design outcomes

Primary

Measure	Time frame
dose of morphine use comparing between 2 group 6 , 12 , 24 hr milligram	—

Secondary

Measure	Time frame
Postoperative pain score 6 , 12 , 24 hr point,Postoperative nausea and vomiting 6 , 12 , 24 hr times,Skin reactions at the application site 6 , 12 , 24 hr yes or no	—

Countries

Thailand

Contacts

Public Contactpanjavid patumanusorn

king chulalongkorn memorial hospital

panjavid@gmail.com0971074040

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026